Wells Fargo & Company ALNYLAM PHARMACEUTICALS INC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
710,000
Previous 712,000 0.28%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-2,000 Reduced 0.28%
710,000 $0
Q1 2025

May 13, 2025
SELL
N/A
-49,000 Reduced 6.44%
712,000 $0
Q4 2024

Feb 12, 2025
SELL
N/A
-2,262,000 Reduced 74.83%
761,000 $0
Q3 2024

Nov 13, 2024
BUY
N/A
241,000 Added 8.66%
3,023,000 $0
Q2 2024

Aug 13, 2024
SELL
N/A
-3,024,000 Reduced 52.08%
2,782,000 $0
Q1 2024

May 10, 2024
SELL
N/A
-1,782,000 Reduced 23.48%
5,806,000 $0
Q4 2023

Feb 09, 2024
BUY
N/A
35,000 Added 0.46%
7,588,000 $0
Q3 2023

Nov 13, 2023
BUY
N/A
7,553,000 New
7,553,000 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email